ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, published by COGNIZANT COMMUNICATION CORP, is a pivotal journal that delves into the intricate relationship between acupuncture, electro-therapeutics, and their applications in the fields of anesthesiology, pain medicine, and complementary therapies. With an ISSN of 0360-1293 and an E-ISSN of 2167-9010, this esteemed journal has been serving the academic community since 1976 and will continue to publish groundbreaking research until 2024. Despite its current positioning within the Q4 quartiles for both anesthesiology and complementary medicine, ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH remains a valuable platform for disseminating innovative studies that push the boundaries of traditional pain management and neuroscience. Researchers, students, and professionals interested in exploring contemporary therapeutic modalities will find this journal an indispensable resource for understanding the efficacy and applications of acupuncture and electro-therapeutics. With a focus on advancing knowledge in these domains, the journal aims to foster a deeper understanding of integrative approaches to health and wellness.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

Chinese Medicine is a distinguished open-access journal published by BMC, focusing on the advancement of knowledge and practice in the domain of complementary and alternative medicine. With the ISSN 1749-8546, this journal has established itself as an important resource for researchers, professionals, and students interested in the integration of traditional Chinese medicine with modern scientific practices. Since its inception in 2006, it has garnered a notable reputation, achieving a Q1 ranking in Complementary and Alternative Medicine and Q2 in Pharmacology for 2023, reflecting its high impact and relevance within the academic community. The journal's commitment to disseminating quality research is evident in its Scopus rankings, placing it in the top decile for medicine and pharmacology disciplines. Open access since its launch, Chinese Medicine promotes widespread accessibility and encourages collaborative scholarly efforts in investigating the efficacy and applications of traditional practices in contemporary healthcare. By fostering a platform for rigorous discourse and innovative research, this journal serves as an essential conduit for advancing the understanding of Chinese medicine's role in global health.

Deutsche Zeitschrift für Akupunktur is a distinguished journal published by Springer Heidelberg, focusing on the dynamic field of complementary and alternative medicine, with a particular emphasis on acupuncture practices and research. Established in 1984, the journal has been a platform for insightful articles that contribute to the understanding and advancement of acupuncture within the broader context of clinical neurology and medicine. Although its coverage in major databases like Scopus was discontinued in 2017, the journal retains relevance through its unique insights and the depth of its contributions during its operational years. As evidenced by its ranking in the lower quartiles of Scopus for its respective categories, the journal offers an opportunity for emerging scholars and seasoned professionals alike to engage with pioneering research and clinical applications. Importantly, while it does not offer open access, the journal serves as a vital resource for those dedicated to exploring the therapeutic potentials of acupuncture and enhancing patient care through alternative medicine approaches.

Current Traditional Medicine, published by Bentham Science Publishers, is an esteemed open-access journal that has been at the forefront of disseminating research in the field of Complementary and Alternative Medicine since its inception in 2015. With ISSN 2215-0838 and E-ISSN 2215-0846, this journal aims to foster scholarly dialogue and innovation by providing a platform for the publication of high-quality studies, reviews, and clinical insights concerning traditional medicine practices and their integration with modern healthcare. Acknowledging the growing relevance of these subjects, Current Traditional Medicine holds a Q3 quartile ranking in Complementary and Alternative Medicine and is positioned within the 30th percentile among its peers. The journal serves as a pivotal resource for researchers, professionals, and students alike, encouraging exploration and advancement in the fields of pharmacology, drug discovery, and herbal medicine. Readily accessible, it ensures that cutting-edge research reaches a global audience, thereby significantly contributing to the evolving landscape of health sciences.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

Integrative Cancer Therapies, published by SAGE Publications Inc, is a leading journal dedicated to advancing the multidisciplinary field of cancer treatment through complementary and alternative medicine. With an ISSN of 1534-7354 and an E-ISSN of 1552-695X, this journal has been pivotal in disseminating impactful research since its inception in 2002, establishing itself as a resource for practitioners, researchers, and academicians. As a distinguished publication categorized in the Q1 quartile for Complementary and Alternative Medicine and Q3 for Oncology, it positions itself within the top echelons of its field, as evidenced by its Scopus rankings - 25/105 in Complementary and Alternative Medicine and 178/404 in Oncology. The objective of Integrative Cancer Therapies is to provide a platform for innovative approaches and studies that explore integrative methodologies in cancer care, thereby enhancing therapeutic outcomes and promoting holistic treatment perspectives. Researchers and healthcare professionals who contribute to or follow this journal gain access to cutting-edge findings and diverse perspectives that drive the evolution of cancer therapy.

The Chinese Journal of Integrative Medicine, published by SPRINGER, serves as a pivotal platform for advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has been committed to disseminating high-quality research and innovative practices that integrate traditional Chinese medicine with modern medical science. With an impressive categorization in the 2023 metrics, ranking Q2 in Complementary and Alternative Medicine and Q3 in both Medicine (miscellaneous) and Pharmacology (medical), the journal highlights its recognition within the global academic landscape. Researchers and practitioners alike can benefit from its rigorous peer-reviewed articles, making significant contributions to the understanding and application of integrative health strategies. While it currently does not support open access, the journal remains a key resource for those dedicated to exploring the synergy between ancient practices and contemporary medical approaches, thus enhancing patient care and outcomes.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.

World Journal of Acupuncture-Moxibustion is a premier academic publication focusing on the fields of acupuncture and moxibustion, providing a platform for cutting-edge research and advancements in complementary and alternative medicine. Published by KEAI PUBLISHING LTD, this journal serves an international audience, fostering scholarly dialogue on evidence-based practices, methodologies, and clinical outcomes. With a commendable designation of Q3 in the 2023 category of Complementary and Alternative Medicine, it ranks 74th out of 105 journals in the field based on Scopus metrics, reflecting its significant contribution to the discipline. Although it operates under a subscription model, the journal's commitment to advancing knowledge from 2012 to 2024 makes it an essential resource for researchers, practitioners, and students aiming to deepen their understanding of acupuncture and its applications. For those in pursuit of innovative healing techniques and holistic health, the World Journal of Acupuncture-Moxibustion stands as a vital forum for exploring the intersection of traditional practices and modern scientific inquiry.